Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-004399

Chief Legal Officer sold 294 shares at $1.99 ($585)

From the SEC's structured data for this filing

Trades in this filing

Miller Mary · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-05 Sale : show line 1 in the form −294 $1.99 $585 81,715 D
Open-market sales · 294 sh · avg $1.99 · $585
Loading xslF345X06/form4.xml…